1. Home
  2. RGP vs RANI Comparison

RGP vs RANI Comparison

Compare RGP & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.41

Market Cap

138.0M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.06

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
RANI
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
126.8M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RGP
RANI
Price
$4.41
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$7.00
$7.50
AVG Volume (30 Days)
251.5K
676.4K
Earning Date
04-08-2026
05-07-2026
Dividend Yield
6.85%
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
$551,331,000.00
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$3.06
$0.39
52 Week High
$6.07
$3.87

Technical Indicators

Market Signals
Indicator
RGP
RANI
Relative Strength Index (RSI) 65.19 60.04
Support Level $4.22 $0.46
Resistance Level $4.86 $1.22
Average True Range (ATR) 0.18 0.07
MACD 0.03 0.02
Stochastic Oscillator 83.97 80.34

Price Performance

Historical Comparison
RGP
RANI

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: